Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinical results show significant improvements in maternal and infant outcomes including reduced C-section rates (34%), preterm delivery/NICU stays (28%), preeclampsia incidence (18%), increased breastfeeding initiation rate (91%), improved perinatal mental health identification, increased natural conception rates, reduced multiple gestations, higher return-to-work after parental leave.
Over 50 peer-reviewed publications validate the clinical impact of the programs.
The company has served over 22 million family journeys since its founding.
Programs are evidence-based with dynamic risk assessment/intervention capabilities.
Used by over 2,000 employers/health plans as a covered benefit.
Demonstrated reduction in healthcare costs for payers/employers.
Platform supports early identification of high-risk pregnancies via digital assessments/coaching.
Collaborates with leading universities/research groups for ongoing validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ovia Health.